首页> 外国专利> method for treating pleural effusion of tuberculous origin

method for treating pleural effusion of tuberculous origin

机译:结核源性胸腔积液的治疗方法

摘要

A method for treating pleural effusion of tuberculous origin, wherein the preoperative diagnostic pneumothorax application is made with the subsequent spiral computed tomography. The autopsy soft tissue is made with the length to in depth to the parietal pleura and finger penetration in the free area in pleural cavity with partial separation of pleural connections. The first toracoport is introduced with a camera and permanent image video fixation. The location of the second and third toracoports insertions is determined under palpation and visual control. The diaphragmolysis is performed, linear parietal pleuroectomy is made below the apical zone followed by microbiological analysis. The mediastynodiaphragmal pleural surface is purified of fibrinous layers. The sanitation of pleural cavity with antiseptic solution is used and under visual control is drained by "Blake" drainage and interlobar intervals, respectively, with microirrigator. At the end of the operation and daily intrapleural administration are performed with 10.0 ml of 0.2% solution of local ropivacaine anesthetic and 10.0 ml of combined antibacterial hixoside drug. Immediately after the operation drainage and microirrigator are connected to active aspiration.
机译:一种治疗结核源性胸腔积液的方法,其中术前诊断性气胸的应用是通过随后的螺旋计算机断层扫描进行的。尸体解剖软组织的长度达到顶壁胸膜的深度,并在胸膜腔的自由区域穿入手指,且胸膜连接部分分离。引入了第一个toracoport相机和永久图像视频固定装置。在触诊和视觉控制下确定第二和第三toracoports插入的位置。进行膜溶解,在根尖区以下进行线性顶叶胸膜切除术,然后进行微生物学分析。内侧sty下胸膜表面是纤维化层。使用具有消毒液的胸膜腔卫生,并在视觉控制下分别通过微冲洗器通过“ Blake”引流和叶间间隔引流。在手术结束时,每天用10.0 ml 0.2%的局部罗哌卡因麻醉剂溶液和10.0 ml联合抗菌的hixoside药物进行胸膜内给药。手术后立即将引流器和微冲洗器连接到主动抽吸装置上。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号